Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


Hepatitis C Cases Could Be Cured By Novel Oral Drug Regimen (July 31, 2014)

According to the results of two new clinical studies published in The Lancet, two new pill-only antiviral drug regimens for hepatitis C virus infection provide shorter and more effective treatment options... Continue Reading

Largest Study to Date of Pembrolizumab in Advanced Melanoma Shows Promising Activity (July 31, 2014)

The investigational anti-PD-1 antibody pembrolizumab is demonstrating promising survival rates among patients with advanced melanoma. Data from an ongoing Phase 1 trial of the drug were presented at the... Continue Reading

Investigational Drug Pembrolizumab Shows Anticancer Activity in Advanced Melanoma (July 30, 2014)

Recent findings reported in The Lancet indicate that the investigational drug pembrolizumab may be effective in patients with advanced melanoma that has progressed after treatment with Yervoy® (ipilimumab).[1]... Continue Reading

Jakafi® (ruxolitinib) Product Label Expanded to Include Overall Survival Data and Additional Safety and Dosing Information (July 30, 2014)

Jakafi is a prescription medicine approved by the U.S. Food and Drug Administration to treat people with intermediate or high-risk myelofibrosis (MF), including primary MF, post–polycythemia vera MF... Continue Reading

Studies Evaluate Robot Assisted Cystectomy Treatment of Bladder Cancer (July 29, 2014)

The bladder is a hollow organ located in the pelvis. Its primary function is to store urine. The bladder has a muscular wall that allows it to get larger and smaller as urine is stored or emptied. Bladder... Continue Reading

New MD Anderson Research Questions Early Prostate Cancer Treatment Options (July 28, 2014)

Researchers at The University of Texas MD Anderson Cancer Center recently published their latest findings on the role a diagnosing urologist plays in deciding whether older men with low-risk prostate... Continue Reading

Study of Combination Therapy in Cutaneous Melanoma Stopped Early to Allow Crossover (July 25, 2014)

An Independent Data Monitoring Committee recently recommended that a clinical study of the combination treatment Mekinist™ (trametinib) plus Tafinlar™ (dabrafenib) versus Zelboraf® (vemurafenib) for... Continue Reading

FDA Approves Beleodaq for Peripheral T-cell Lymphoma (July 24, 2014)

The FDA announces its approval of Beleodaq (belinostat), a histone deacetylase inhibitor for treating peripheral T-cell lymphoma (PTCL), based on the results of the BELIEF study that found an overall response... Continue Reading

HPV Testing Found to Be More Effective Than Pap Smears in Evaluating Cervical Cancer Risk (July 23, 2014)

Researchers at the National Cancer Institute reported that testing for HPV (human papillomavirus) is the most effective way to determine whether a woman is at risk for developing cervical cancer in the... Continue Reading

Revlimid, Velcade, and Dexamethasone Followed by Revlimid Maintenance Appears Promising (July 22, 2014)

Researchers from France recently published the preliminary results of a clinical trial evaluating chemotherapy induction and consolidation treatment with Revlimid (lenalidomide), Velcade (bortezomib),... Continue Reading

Dramatic Results Seen in Early Trials of Novel Lymphoma Treatment (July 21, 2014)

A new treatment approach for B-Cell lymphoma patients developed at the National Cancer Institute (NCI) and licensed to Kite Pharmaceuticals is showing dramatic results in pilot clinical trials. The treatment,... Continue Reading

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat... Continue Reading

Ask the Expert: Polycythemia Vera, Essential Thrombocythemia and Myelofibrosis (July 12, 2014)

CancerConnect Presents: Ask the Expert with Dr. Mesa Ruben A. Mesa, MD recently participated in the CancerConnect guest moderator series on myeloproliferative neoplasms (MPN).  Dr. Mesa answered your... Continue Reading

In Advanced Pancreatic Cancer, Eloxatin® with Folinic Acid and Fluorouracil May Improve Survival (July 10, 2014)

In a Phase III study, the addition of the chemotherapy drug Eloxatin® (oxaliplatin) to the chemotherapy regimen of folinic acid and fluorouracil (5-FU) improved outcomes in patients with advanced pancreatic... Continue Reading

Initial Treatment with VELCADE® Improves Outcomes of Patients with Mantle Cell Lymphoma (July 10, 2014)

The results of a large comparative clinical trial presented at the annual meeting of the American Society of Clinical Oncology demonstrated that VELCADE® (bortezomib)-based combination therapy demonstrated... Continue Reading

TAS-102 Improves Survival in Advanced Colorectal Cancer (July 9, 2014)

Researchers recently reported that the new combination agent TAS-102 improves overall survival in patients whose metastatic colorectal cancer is refractory to standard therapies. These results were recently... Continue Reading

Trial Evaluating Nivolumab in Advanced Melanoma Halted Early Because of Superior Results (July 8, 2014)

Bristol-Myers Squibb announced on Tuesday that its clinical trial evaluating cancer immunotherapy nivolumab, which is being developed in advanced melanoma was halted early after it was determined that... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (July 7, 2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women... Continue Reading

More Effective Colorectal Cancer Prevention with Colonoscopy Doctor with High Rate of Polyp Detection (July 3, 2014)

Recent findings suggest that for more effective colorectal cancer prevention, it’s best to choose a physician for colonoscopy with a higher rate of precancerous polyp detection; meaning that he or she... Continue Reading

Study Shows Polypectomy as Effective as Partial Colon Resection (July 2, 2014)

A team from Stony Brook University reported that patients requiring removal of colon polyps could be effectively treated with laparoscopic-assisted polypectomy (LACP) and that the procedure required fewer... Continue Reading

Aspirin Reduces Risk of Pancreatic Cancer (July 1, 2014)

The results of a recent study suggest that regular aspirin use reduces the risk of pancreatic cancer by half.  Clinical studies have also found that regular aspirin use can reduce the risk for colon,... Continue Reading

Updated Analysis of the MPACT Study in Advanced Pancreatic Cancer Demonstrates Continued Improvement in Survival for Abraxane-based Chemotherapy (July 1, 2014)

A follow up report on the results of the Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) study of Abraxane® (nab-paclitaxel) in combination with Gemzar® (gemcitabine) in previously untreated... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (June 30, 2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex®... Continue Reading

Torisel Improves Event-Free Survival in Rhabdomyosarcoma Patients (June 27, 2014)

In a study presented at the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that Torisel® (temsirolimus) added to a chemotherapy regimen improved event-free survival... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS